Albert David Ltd. Financials

15:48 Oct 28

Albert David Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
838.10
+30.50 (+3.78%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Albert David Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
838.10
+30.50 (+3.78%)
15:48 Oct 28
Quality
image/svg+xml

36/100
Medium Financial Strength

Valuation
image/svg+xml

35/100
Mid Valuation

Technical

51/100
Technically Neutral

Strength

7

Weakness

9

Opportunity

0

Threats

0

4.38 %

ROE %

3.36 %

ROA %

11.03

EPS

687.70

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
313.51 341.56 362.46 345.77 326.98
Operating Expenses +
272.72 297.22 315.58 342.74 335.48
Raw Material
112.56 127.69 128.17 130.61 125.35
Increase Decrease in Cost
2.38 -4.6 -1.77 -14.33 -14.09
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
85.38 81.07 88.43 109.02 109.03
Miscellaneous Expenses
194.6 221.36 229.25 238.36 115.19
Operating Profit
40.79 44.34 46.88 3.03 -8.5
Other Income
15.84 15.4 57.55 29.58 28.56
Depreciation
8.81 8.55 6.83 6.97 7.58
Interest
0.53 0.46 0.32 0.41 0.87
Profit before tax and exceptio..
47.3 50.74 97.29 25.23 11.61
Exceptional Items
0 0 0 0 0
PBT
47.3 50.74 97.29 25.23 11.61
Provision for Taxation
12.04 14.56 21.87 8.03 5.31
Net Profit
35.26 36.17 75.42 17.2 6.29
NET Profit after MI
0 0 0 0 0
EPS
61.78 63.39 132.15 30.14 11.03
Operating Profit Margin (%)
13.01 12.98 12.93 0.88 -2.6
Net Profit Margin (%)
11.25 10.59 20.81 4.97 1.92

Albert David Ltd. Shareholding

All Data in Percentage (%)

Sep 25 Jun 25 Mar 25 Dec 24 Sep 24
Promoter 62.20 62.20 62.20 62.10 62.10
FII 0.60 0.80 1.00 0.90 0.90
MF 0.00 0.00 0.00 0.00 0.00
Others 1.60 1.70 1.60 1.60 1.60
Shareholder Shares Holding %
Download Our App On: